BioSpace News Archive

Drug Development

FDA Approves First Targeted Radioligand Therapy for Advanced Prostate Cancer

The FDA approved Pluvicto (targeted radioligand therapy) for use in adults with PSMA-positive mCRPC that has already metastasized to other body parts.

March 24, 2022
·
2 min read
·
Vanessa Doctor, RN
Business

BiondVax Inks Deal for NanoAbs, Totus Doubles Down on AI

Terms of the deal provide BiondVax with an option for a worldwide license to develop and commercialize the NanoAbs, which are also known as VHH-antibodies or nanobodies.

March 24, 2022
·
3 min read
·
Alex Keown
FDA

Pfizer Notches Breakthrough Status in Race to an RSV Vaccine

Pfizer has announced it received Breakthrough Therapy Designation from the FDA for its vaccine candidate intended to prevent infections caused by the respiratory syncytial virus (RSV).

March 24, 2022
·
3 min read
·
Hayley Shasteen
Drug Development

Jazz Doses First Patient in Broad Trial for Promising Cancer Drug

The Phase II trial is evaluating zepzelca as a monotherapy in patients with urothelial carcinoma, large cell neuroendocrine carcinoma of the lung and HRD tumors.

March 24, 2022
·
3 min read
·
Hayley Shasteen
Drug Development

In Expected Decision, FDA Rejects Lilly’s Sintilimab in NSCLC

The U.S. Food and Drug Administration rejected Eli Lilly’s Biologics License Application, issuing a Complete Response Letter for the company’s PD-1 checkpoint inhibitor sintilimab.

March 24, 2022
·
3 min read
·
Mark Terry
Drug Development

AstraZeneca’s Imfinzi Fails to Boost Survival in Cervical Cancer

AstraZeneca shared that using imfinzi alongside chemoradiotherapy did not meet statistical significance in improving progression-free survival versus using CRT alone.

March 24, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Stalled by COVID-19, TB Research Needs to Make Up for Lost Time

In honor of March 24, World TB Day, BioSpace looks at clinical trials and eradication efforts occurring today.

March 24, 2022
·
5 min read
·
Rosemary Scott
Policy

U.S. Judge Tosses Genentech Lawsuit Against Sandoz

A federal judge in Delaware tossed out a lawsuit by Genentech, Inc., a Roche company, accusing Novartis’ Sandoz division of patent infringement.

March 24, 2022
·
3 min read
·
Mark Terry
Drug Development

Research Roundup: Halting Memory Loss in Alzheimer’s, COVID-19 and Diabetes

A recent study in mice was able to halt memory decay in a model of Alzheimer’s disease. Another study found that even mild infection increased the risk of new-onset type 2 diabetes, although the risk increased with the severity of COVID-19.

March 24, 2022
·
5 min read
·
Mark Terry
Celsius Nets $83M to Bring Precision IBD Treatment to Trial

Celsius Therapeutics raised $83 million in funding, paving the way for several ambitious projects announced in its recently released key initiatives for 2022.

March 24, 2022
·
2 min read
·
Hannah Chudleigh